Back to Results
First PageMeta Content
Organic chemistry / Atypical antipsychotics / Antipsychotic / Akathisia / Extrapyramidal / Sulpiride / Schizophrenia / Psychiatry / Health / Extrapyramidal symptoms


AB-Biotics acquires a patent for predicting antipsychotic-induced extrapyramidal symptoms  This DNA-based method can predict the risk of a patient treated with antipsychotic drugs developing side effects affecting mov
Add to Reading List

Document Date: 2013-10-28 06:34:27

Open Document

File Size: 25,66 KB

Share Result on Facebook

City

Consorcio Centro / Barcelona / /

Company

GlaxoSmithKline / AB-Biotics / /

Continent

America / Asia / Europe / /

Country

Mexico / Spain / Brazil / /

/

Event

M&A / /

Facility

University of Barcelona / Hospital Clínic de Barcelona / /

IndustryTerm

biotechnology / pharmaceutical industries / biotech unique solutions / food / /

MedicalCondition

schizophrenia / parkinsonism / epilepsy / muscle rigidity / depression / bipolar disorder / akathisia / /

Organization

Spanish Alternative / Instituto de Investigaciones Biomédicas August Pi / University of Barcelona / /

Person

Salud Mental / Nuria Peláez / /

Position

Chief Communications Officer / /

Technology

biotechnology / /

SocialTag